Third Circuit Shows No Love For Lovenox® Bundling Theory
Posted 05/6/16
By Ankur Kapoor
Citing the well-known maxim that the antitrust laws are concerned with “the protection of competition, not competitors,” the U.S. Court of Appeals for the Third Circuit on Wednesday for Defendant Sanofi Aventis on Plaintiff Eisai, Inc.’s claim that Sanofi foreclosed
competition in the market for anticoagulant drugs administered in hospitals.
Eisai alleged that...